Patient-centered approach key for T2DM management

April 23, 2012
Patient-Centered approach key for T2DM management

(HealthDay) -- Treatment of type 2 diabetes should be personalized in a patient-centered approach, with diet, exercise, and education forming the basis of any treatment program, supplemented by medications as necessary, according to a joint position statement issued by the American Diabetes Association and the European Association for the Study of Diabetes, published online April 19 in Diabetes Care.

Silvio E. Inzucchi, M.D., from the Yale University School of Medicine in Haven Hospital, Conn., and colleagues reviewed the literature and examined the evidence to develop recommendations for antihyperglycemic therapy in nonpregnant adults with type 2 diabetes.

The authors recommend that glycemic targets and glucose-lowering therapies should be individualized for each patient. Diet, exercise, and education are still the basis of any treatment program for type 2 diabetes, and resources should be made available. Metformin should be the first-line therapy for hyperglycemia, unless there are prevalent contraindications. Data are limited for subsequent therapies; combination of an additional one to two oral or injectable agents is reasonable, with emphasis on minimizing side effects. Ultimately, a substantial proportion of patients will require , either alone or in combination with other agents. Where possible, treatment decisions should be made in conjunction with the patients, focusing on specific needs, preferences, and values. A major focus of therapy should be reduction of cardiovascular risk.

"These recommendations should be considered within the context of the needs, preferences, and tolerances of each patient; individualization of treatment is the cornerstone of success," the authors write.

Several authors disclosed to the pharmaceutical industry.

Explore further: Concern over intensive treatment for patients with type 2 diabetes

More information: Full Text

Related Stories

Diabetes groups issue new guidelines on blood sugar

April 19, 2012

(HealthDay) -- Type 2 diabetes is a complex metabolic disorder, and treating the disease often requires a personalized, multi-pronged approach, say new expert guidelines on treating high blood sugar levels, issued Thursday.

Recommended for you

Engineered hot fat implants reduce weight gain in mice

August 20, 2015

Scientists at the University of California, Berkeley, have developed a novel way to engineer the growth and expansion of energy-burning "good" fat, and then found that this fat helped reduce weight gain and lower blood glucose ...

Promising progress for new treatment of type 1 diabetes

July 30, 2015

New research from Uppsala University shows promising progress in the use of anti-inflammatory cytokine for treatment of type 1 diabetes. The study, published in the open access journal Scientific Reports, reveals that administration ...

Bacteria may cause type 2 diabetes

June 1, 2015

Bacteria and viruses have an obvious role in causing infectious diseases, but microbes have also been identified as the surprising cause of other illnesses, including cervical cancer (Human papilloma virus) and stomach ulcers ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.